Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Res ; 26(3A): 1815-9, 2006.
Article in English | MEDLINE | ID: mdl-16827112

ABSTRACT

Platinum (II) complexes are accredited with biological activities. New complexes with thiepane dioxide diamine as ligands, characterized by defined stereochemical features, a flexible 7-membered thiepane moiety and by C2 symmetry, were prepared. The complexes, related to the diamino cyclohexane family of platinum complexes, were soluble in dimethyl sulfoxide with the solvent substituting one chloride ion. These positively-charged complexes were tested against a human carcinoma cell line A431 and its cisplatin-resistant counterpart A431/Pt and were found to show: i) capability in bypassing cisplatin-resistance; ii) cytotoxicity comparable to that of oxaliplatin; iii) lower activity than cisplatin. In both cells lines, [PtCl(DACH)(DMSO)]+ was more cytotoxic than oxaliplatin. The best activity was shown by the platinum complexes with ligands which presented C2 symmetry.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Organoplatinum Compounds/chemistry , Organoplatinum Compounds/pharmacology , Antineoplastic Agents/chemical synthesis , Cell Line, Tumor , Cisplatin/pharmacology , Drug Resistance, Neoplasm , Drug Screening Assays, Antitumor , Female , Humans , Ligands , Organoplatinum Compounds/chemical synthesis , Oxaliplatin , Oxides/chemical synthesis , Oxides/chemistry , Oxides/pharmacology , Stereoisomerism , Thiepins/chemical synthesis , Thiepins/chemistry , Thiepins/pharmacology , Uterine Cervical Neoplasms/drug therapy
2.
Obes Surg ; 12(6): 802-4, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12568185

ABSTRACT

BACKGROUND: Hepatic steatosis, nonalcoholic steatohepatitis and cryptogenetic cirrhosis are frequent in an obese population. Therefore, it is wise to submit all obese patients with significant alterations in hepatic function tests to transparietal liver biopsy. The aim of this study is to determine the hepatic conditions of morbidly obese patients during bariatric surgery by means of a wedge liver biopsy, to avoid any eventual hepatic damage being ascribed to the surgical procedure. METHODS: This prospective study entails 216 consecutive patients, whose work-up included liver function tests, before undergoing vertical gastroplasty and wedge liver biopsy. Histology was assessed for hepatic steatosis, necroinflammatory activity and liver fibrosis/cirrhosis. RESULTS: Abnormal preoperative liver function tests were detected in 65 patients, in 52 unexpectedly. Histologically, significant steatosis was found in 168 patients (77.8%); necroinflammatory activity in 13 (6.0%); liver fibrosis in 46 (21.3%), 5 of whom (2.3%) were found to have an asymptomatic and unknown liver cirrhosis. CONCLUSION: In morbidly obese patients, the incidence of histological liver damage is very high, despite acceptable liver function tests. In addition to steatosis, however, a "second hit" to induce necrosis and inflammation, favoring the development of significant fibrosis, is not essential. Being obese is an independent risk factor for liver damage and could contribute to liver fibrosis either alone or in association with other insulting factors. The identification of obese patients with septal fibrosis/cirrhosis, at surgery, is of considerable interest in clinical practice, mainly under the aspect of prognosis and liability.


Subject(s)
Liver/pathology , Obesity, Morbid/pathology , Adolescent , Adult , Female , Humans , Liver/physiopathology , Liver Cirrhosis/physiopathology , Liver Function Tests , Male , Middle Aged , Obesity, Morbid/physiopathology , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...